Viewing Study NCT01767532


Ignite Creation Date: 2025-12-24 @ 9:43 PM
Ignite Modification Date: 2026-01-02 @ 11:44 PM
Study NCT ID: NCT01767532
Status: COMPLETED
Last Update Posted: 2017-06-22
First Post: 2013-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bioequivalence Study of Cephalexin Suspension 125
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module